Ausgabe 1/2000
Inhalt (13 Artikel)
Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
R Hájek, AW Butch
Myelodysplasia and apoptosis: new insights into ineffective erythropoiesis
AA van de Loosdrecht, E Vellenga
C-erb-B2 expression and response to treatment in metastatic breast cancer
W R Bezwoda
Serum erythropoietin level in anemic cancer patients
M Ozguroglu, B Arun, G Demir, F Demirelli, NM Mandel, E Buyukunal, S Serdengecti, B Berkarda
Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas
V Wagner, J Rudi, H Näher, W Stremmel
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial
A A Ezzat, E M Ibrahim, R K Stuart, D Ajarim, S Bazarbashi, M O El-Foudeh, M Rahal, A Al-Sayed, John Berry
Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385)
AN Leaf, BC Wolf, JM Kirkwood, RE Haselow
Induction of matric metalloprotease-7 is common in mucinous ovarian tumors including early stage disease
K Shigemasa, H Tanimoto, K Sakata, N Nagai, TH Parmley, K Ohama, TJ O'Brien
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute Experience
S. Viviani, P Notti, V Bonfante, P Verderio, P Valagussa, G Bonadonna
Campath-1H in B-chronic lymphocytic leukemia: report on a patient treated thrice in a 3 year period
GA Pangalis, MN Dimopoulou, MK Angelopoulou, CH Tsekouras, MP Siakantaris